Recombinant expressing angiopep-2 fused anti-VEGF single chain Fab (scFab) could cross blood–brain barrier and target glioma
Abstract In 2009, the FDA approved bevacizumab for the treatment of adult patients diagnosed with recurrent glioblastoma. However, the poor permeability of the macromolecules across the blood–brain barrier, determined by multifactorial anatomical and physiological milieu, restricts the clinical ther...
Na minha lista:
| Principais autores: | , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
SpringerOpen
2019-10-01
|
| coleção: | AMB Express |
| Assuntos: | |
| Acesso em linha: | http://link.springer.com/article/10.1186/s13568-019-0869-3 |
| Tags: |
Sem tags, seja o primeiro a adicionar uma tag!
|